Christian Rolfo: Natasha Leighl highlights liquid biopsy for TKI monitoring
Christian Rolfo, Division Director of Medical Oncology and Associate Director for Early Phase Clinical Trials at The James Comprehensive Cancer Center, posted the following on X:
“Prof Natasha Leighl giving a great presentation on Liquid Biopsy for TKI monitoring in the 2024 Hot Topic in Basic and Translational Science: Tolerance and Resistance to Targeted Therapies.”
More posts Christian Rolfo.
Christian Rolfo MD, PhD, MBA, Dr.hc. is the Division Director of Medical Oncology and Associate Director for Early Phase Clinical Trials at The James Comprehensive Cancer Center, The Ohio State University. He also serves as a Professor of Internal Medicine -Oncology at Ohio State University Comprehensive Cancer Center-James Cancer Hospital and Solove Research Institute. He has authored over 350 scientific articles & contributions to book chapters.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023